Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathryn A Giblin

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|May 19, 2010
Is epilepsy a preventable disorder? New evidence from animal modelsKathryn A Giblin, Hal Blumenfeld
Journal of Chemical Information and Modeling|August 21, 2018
Prospectively Validated Proteochemometric Models for the Prediction of Small-Molecule Binding to Bromodomain ProteinsKathryn A Giblin, Samantha J Hughes, Helen Boyd, et al.
Drug Discovery Today|November 30, 2020
Uncertainty quantification in drug designLewis H Mervin, Simon Johansson, Elizaveta Semenova, et al.
Bioorganic & Medicinal Chemistry|July 19, 2021
De novo design with deep generative models based on 3D similarity scoringKostas Papadopoulos, Kathryn A Giblin, Jon Paul Janet, et al.
Bioorganic & Medicinal Chemistry|August 30, 2021
Erratum to "De novo design with deep generative models based on 3D similarity scoring" [Bioorg. Med. Chem. 44 (2021) 116308]Kostas Papadopoulos, Kathryn A Giblin, Jon Paul Janet, et al.
Chemical Research in Toxicology|December 18, 2020
New Associations between Drug-Induced Adverse Events in Animal Models and Humans Reveal Novel Candidate Safety TargetsKathryn A Giblin, Danilo Basili, Avid M Afzal, et al.
Journal of Cheminformatics|November 18, 2021
DockStream: a docking wrapper to enhance de novo molecular designJeff Guo, Jon Paul Janet, Matthias R Bauer, et al.
Chemical Research in Toxicology|October 24, 2018
Information-Derived Mechanistic Hypotheses for Structural CardiotoxicityFredrik Svensson, Azedine Zoufir, Samar Mahmoud, et al.
Journal of Medicinal Chemistry|August 12, 2024
Accelerated Discovery of Carbamate Cbl-b Inhibitors Using Generative AI Models and Structure-Based Drug DesignTaylor R Quinn, Kathryn A Giblin, Clare Thomson, et al.
ACS Medicinal Chemistry Letters|December 20, 2023
Discovery of a Novel Benzodiazepine Series of Cbl-b Inhibitors for the Enhancement of Antitumor ImmunityJeffrey A Boerth, Alex J Chinn, Marianne Schimpl, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|May 19, 2010
Is epilepsy a preventable disorder? New evidence from animal modelsKathryn A Giblin, Hal Blumenfeld
Journal of Chemical Information and Modeling|August 21, 2018
Prospectively Validated Proteochemometric Models for the Prediction of Small-Molecule Binding to Bromodomain ProteinsKathryn A Giblin, Samantha J Hughes, Helen Boyd, et al.
Drug Discovery Today|November 30, 2020
Uncertainty quantification in drug designLewis H Mervin, Simon Johansson, Elizaveta Semenova, et al.
Bioorganic & Medicinal Chemistry|July 19, 2021
De novo design with deep generative models based on 3D similarity scoringKostas Papadopoulos, Kathryn A Giblin, Jon Paul Janet, et al.
Bioorganic & Medicinal Chemistry|August 30, 2021
Erratum to "De novo design with deep generative models based on 3D similarity scoring" [Bioorg. Med. Chem. 44 (2021) 116308]Kostas Papadopoulos, Kathryn A Giblin, Jon Paul Janet, et al.
Chemical Research in Toxicology|December 18, 2020
New Associations between Drug-Induced Adverse Events in Animal Models and Humans Reveal Novel Candidate Safety TargetsKathryn A Giblin, Danilo Basili, Avid M Afzal, et al.
Journal of Cheminformatics|November 18, 2021
DockStream: a docking wrapper to enhance de novo molecular designJeff Guo, Jon Paul Janet, Matthias R Bauer, et al.
Chemical Research in Toxicology|October 24, 2018
Information-Derived Mechanistic Hypotheses for Structural CardiotoxicityFredrik Svensson, Azedine Zoufir, Samar Mahmoud, et al.
Journal of Medicinal Chemistry|August 12, 2024
Accelerated Discovery of Carbamate Cbl-b Inhibitors Using Generative AI Models and Structure-Based Drug DesignTaylor R Quinn, Kathryn A Giblin, Clare Thomson, et al.
ACS Medicinal Chemistry Letters|December 20, 2023
Discovery of a Novel Benzodiazepine Series of Cbl-b Inhibitors for the Enhancement of Antitumor ImmunityJeffrey A Boerth, Alex J Chinn, Marianne Schimpl, et al.
Pageof 2